Frankfurt, Germany

Rainer J Helbig

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer J Helbig. Retrieved from https://idiyas.com/inventor/rainer-j-helbig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer J Helbig: Innovator in Injectable Solutions

Introduction

Rainer J Helbig is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable solutions. His work focuses on enhancing the efficacy and safety of medical treatments.

Latest Patents

Rainer J Helbig holds 1 patent for his innovative formulation titled "Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide." This patent describes a ready-to-use injectable solution with a pH ranging from 10.2 to 11.2, which contains a mixture of alkali metal salts without the addition of a buffer. The process for preparing this solution is also detailed in the patent.

Career Highlights

Throughout his career, Rainer has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug formulation and delivery systems, showcasing his expertise in the field.

Collaborations

Rainer has collaborated with Richard Leeb, further enhancing the innovative potential of their projects. Their partnership has led to the development of effective pharmaceutical solutions.

Conclusion

Rainer J Helbig's contributions to injectable solutions demonstrate his commitment to improving medical treatments. His innovative work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…